EFFECT OF INHALED PROSTAGLANDIN-E2 ON BRONCHIAL REACTIVITY TO SODIUM METABISULFITE AND METHACHOLINE IN PATIENTS WITH ASTHMA

被引:57
作者
PAVORD, ID
WISNIEWSKI, A
MATHUR, R
WAHEDNA, I
KNOX, AJ
TATTERSFIELD, AE
机构
[1] Respiratory Medicine Unit, City Hospital
关键词
D O I
10.1136/thx.46.9.633
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Inhaled frusemide protects against the bronchoconstrictor response to a wide range of stimuli that cause bronchoconstriction by indirect mechanisms. One possible explanation for this protection relates to the known ability of frusemide to enhance synthesis of prostaglandin E2 (PGE2). Studies in vitro suggest that PGE2 might protect against indirectly acting bronchoconstrictor challenges rather than those that act directly on airway smooth muscle, though little is known about the effects of PGE2 in vivo. The effect of inhaled PGE2 on the bronchoconstrictor response to inhaled sodium metabisulphite (a stimulus with an indirect action) and methacholine (which acts directly on airway smooth muscle) was studied in nine patients with asthma. Subjects were studied on four days, inhaling PGE2 (100-mu-g) or placebo in a double blind fashion followed immediately by a cumulative dose challenge with sodium metabisulphite or methacholine. The response to the constrictor stimuli was measured as the provocative dose causing a 20% fall in FEV1 (PD20). There was no significant change in FEV1 after inhaled PGE2 compared with placebo, nor any significant change in the response to methacholine; the geometric mean methacholine PD20 was 0.9-mu-mol after PGE2 and 0.56-mu-mol after placebo (mean difference 0.7 (95% confidence limits -0.1, 1.5) doubling doses). PGE2, however, protected against sodium metabisulphite, the geometric mean sodium metabisulphite PD20 being 11.8-mu-mol after PGE2 and 1.8 mu-mol after placebo (mean difference 2.5 (95% CL 1.9, 3.1) doubling doses). PGE2 conferred significantly greater protection against sodium metabisulphite than methacholine (mean difference 1.8 (95% CL 0.8, 2.8) doubling doses). This suggests that PGE2, like frusemide, has an inhibitory effect on pathways relevant to the bronchoconstriction induced by sodium metabisulphite, with little or no effect on those relevant to methacholine.
引用
收藏
页码:633 / 637
页数:5
相关论文
共 35 条
[1]  
BIANCO S, 1988, LANCET, V2, P252
[2]   PROTECTIVE EFFECT OF INHALED FUROSEMIDE ON ALLERGEN-INDUCED EARLY AND LATE ASTHMATIC REACTIONS [J].
BIANCO, S ;
PIERONI, MG ;
REFINI, RM ;
ROTTOLI, L ;
SESTINI, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (16) :1069-1073
[3]   SENSITIVITY OF THE HUMAN COUGH REFLEX - EFFECT OF INFLAMMATORY MEDIATORS PROSTAGLANDIN-E2, BRADYKININ, AND HISTAMINE [J].
CHOUDRY, NB ;
FULLER, RW ;
PRIDE, NB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (01) :137-141
[4]  
CHRISTMAN B W, 1990, American Review of Respiratory Disease, V141, pA393
[5]   CYCLOOXYGENASE METABOLISM OF ENDOGENOUS ARACHIDONIC-ACID BY CULTURED HUMAN TRACHEAL EPITHELIAL-CELLS [J].
CHURCHILL, L ;
CHILTON, FH ;
RESAU, JH ;
BASCOM, R ;
HUBBARD, WC ;
PROUD, D .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (02) :449-459
[6]   INHALED SODIUM METABISULFITE INDUCED BRONCHOCONSTRICTION - INHIBITION BY NEDOCROMIL SODIUM AND SODIUM CROMOGLYCATE [J].
DIXON, CMS ;
IND, PW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (03) :371-376
[7]  
DIXON CMS, 1989, THORAX, V44, pP868
[8]  
GARDINER PJ, 1986, BRIT J PHARMACOL, V1, P45
[9]  
GIEMBYCZ M A, 1990, American Review of Respiratory Disease, V141, pA396
[10]   BRONCHOCONSTRICTOR AND ANTIBRONCHOCONSTRICTOR PROPERTIES OF INHALED PROSTACYCLIN IN ASTHMA [J].
HARDY, CC ;
BRADDING, P ;
ROBINSON, C ;
HOLGATE, ST .
JOURNAL OF APPLIED PHYSIOLOGY, 1988, 64 (04) :1567-1574